BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1896-01-01
Employees
-
Market Cap
-
Website
https://www.bidmc.org/
Clinical Trials
Related News

Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota

First Posted Date
2011-11-17
Last Posted Date
2017-04-04
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
53
Registration Number
NCT01473368
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer

First Posted Date
2011-11-09
Last Posted Date
2017-03-07
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
50
Registration Number
NCT01468649
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness

Not Applicable
Completed
Conditions
Acute Respiratory Failure
Interventions
Drug: Thiamine
First Posted Date
2011-10-31
Last Posted Date
2018-01-16
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
20
Registration Number
NCT01462279
Locations
🇺🇸

Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, United States

Prospective Evaluation of Computerized Physician Order Entry in the Emergency Department

First Posted Date
2011-10-03
Last Posted Date
2017-04-05
Lead Sponsor
Beth Israel Deaconess Medical Center
Registration Number
NCT01444768
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine

First Posted Date
2011-09-28
Last Posted Date
2017-02-08
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
11
Registration Number
NCT01441765
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Aerosol Inhalation Treatment for Dyspnea

Phase 1
Completed
Conditions
Healthy
Dyspnea
Interventions
Drug: Furosemide
Drug: Saline
First Posted Date
2011-09-27
Last Posted Date
2017-06-14
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
24
Registration Number
NCT01440764
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Kidney Donor Outcomes Cohort (KDOC) Study

Completed
Conditions
Living Donor Nephrectomy
First Posted Date
2011-09-01
Last Posted Date
2018-03-20
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
720
Registration Number
NCT01427452
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

🇺🇸

University of Iowa, Iowa City, Iowa, United States

🇺🇸

Maine Medical Center, Portland, Maine, United States

and more 4 locations

Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota

First Posted Date
2011-08-11
Last Posted Date
2017-07-24
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
32
Registration Number
NCT01414010
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)

Phase 1
Terminated
Conditions
Chronic Myelogenous Leukemia
Interventions
Drug: Arsenic trioxide
First Posted Date
2011-07-20
Last Posted Date
2018-09-06
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
7
Registration Number
NCT01397734
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Phase 2
Completed
Conditions
Schizophrenic Psychoses
Interventions
Drug: Placebo
Drug: n-acetylcysteine
First Posted Date
2011-05-16
Last Posted Date
2017-07-05
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
20
Registration Number
NCT01354132
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Massachusetts Mental Health Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy